Toulouse, January 22, 2026 — Cell-Easy, a CDMO specialized in the development and GMP manufacturing of Advanced Therapy Medicinal Products (ATMPs), announces a new clinical milestone achieved in close collaboration with Toulouse University Hospital (CHU Toulouse). The European Medicines Agency (EMA) has granted Clinical Trial Authorization (CTA) for AMUSE, a Phase 1/2 clinical trial evaluating the safety and efficacy of an allogeneic mesenchymal stromal cell (MSC) therapy in patients with systemic sclerosis presenting perioral fibrosis and functional impairment. [Read more…]
Embryonic Stem Cells – Definition, Uses, and Limitations
Embryonic stem cells are cells that can give rise to all of the tissues types that form a human being. These stem cells are being used in drug development, toxicology testing, and disease reversal, as well as to grow healthy new tissue to heal injuries.
While they are powerful cells, embryonic stem cells are controversial to produce, because they are created from human embryos. For this reason, they have limited use and receive restricted funding. Learn more about these cells below. [Read more…]
How Stem Cell Research Is Shaping the Future of Tissue Regeneration
Tissue regeneration has long been a promising frontier in biomedical science. Conventional medical treatments often focus on managing symptoms or slowing disease progression. However, regenerative medicine aims to repair or replace damaged tissues entirely.
Stem cells are at the center of this transformation because of their ability to self-renew. This makes them valuable for treating diseases such as cancer, diabetes, age-related disorders, and tissue damage. Their versatility supports advances in regenerative medicine, which aims to restore damaged tissues in patients with severe medical conditions.
Advances in cellular biology, biotechnology, and clinical research have steadily expanded the understanding of how stem cells behave. Scientists continue to explore how these unique cells can rebuild damaged structures, stimulate healing processes, and improve patient outcomes. [Read more…]
Revolutionizing Hair Regrowth with Stem Cells and Regenerative Treatments
The quest for a full head of hair has captivated humankind for centuries. Countless individuals, plagued by hair loss and thinning, have sought effective remedies to restore their once-abundant tresses. In recent years, scientific advancements in the field of regenerative medicine have sparked hope with the potential use of stem cells and other innovative treatments for hair regrowth. This article delves into the exciting possibilities offered by these therapies, shedding light on their mechanisms and exploring their current status in the realm of hair restoration. [Read more…]
Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience
CARLSBAD, Calif. – Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell therapies for serious medical conditions, announced the receipt of a novel, induced pluripotent stem cell (iPSC) line containing hypoimmunity edits, from Factor Bioscience Inc. (“Factor”). Generation of the line marks a successful milestone in the strategic collaboration between the two companies, under which Factor developed a proprietary, genetically engineered iPSC line that Lineage can utilize for differentiation into certain cell transplant product candidates. [Read more…]
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 202
- Next Page »